Inhibitor Summary of CDK inhibitors
CDKs Diseases References
Palbociclib CDK4/6 metastatic breast cancer [16-20]
Ribociclib CDK4/6 metastatic breast cancer [22-28]
Abemaciclib CDK4/6 high risk early breast cancer [30-33]
SLS009 CDK9 acute myeloid leukemia, peripheral T-cell lymphoma [36, 37]
TP-1287 broad-range Ewing sarcoma [39]
Alvocidib broad-range acute myeloid leukemia [40]
NUV-422 CDK2/CDK4/CDK6 malignant glioma (discontinued) [41-44]